Last update : 05/05/2021 | Version : 1 | ID : 73814
General | |
Identification | |
Detailed name | HEALTH, PERCEPTION, PRACTICES, AND SOCIAL RELATIONS AND INEQUALITIES AMONG THE GENERAL POPULATION DURING THE COVID-19 CRISIS SEROLOGY (SAPRIS-SERO). |
Sign or acronym | SAPRIS-SERO |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CPP 2020.04.24 bis CNIL 920193 |
General Aspects | |
Medical area |
Immunology Infectious diseases |
Study in connection with Covid-19 |
Yes |
Pathology (details) | COVID-19 |
Health determinants |
Geography Healthcare system and access to health care services Occupation Social and psychosocial factors |
Keywords | SARS-CoV-2 COVID-19 Serology |
Scientific investigator(s) (Contact) | |
Name of the director | CARRAT |
Surname | Fabrice |
Address | 27 rue Chaligny PARIS 75102 |
Unit | IPLESP - U1136 |
Organization | Inserm and Sorbonne University |
Name of the director | ZINS |
Surname | Marie |
Address | Paul Brousse 1- ave Paul Vaillant couturier Villejuif |
marie.zins@inserm.fr | |
Unit | UMS 11 |
Organization | Inserm Paris Saclay Université de Paris |
Name of the director | SEVERI |
Surname | Gianluca |
Address |
Gustave Roussy, 114 rue Edouard Vaillant, F-94805 Villejuif Cedex France |
gianluca.severi@inserm.fr | |
Unit | CESP UMR U1018 |
Organization | Inserm et Université Paris Saclay |
Name of the director | CHARLES |
Surname | Marie-Aline |
Address |
9 cours des humanités, CS50004 93322 Aubervilliers Cedex |
marie-aline.charles@inserm.fr | |
Unit | UMS Ined Inserm Elfe |
Organization | Ined Inserm |
Name of the director | ANCEL |
Surname | Pierre-Yves |
Address |
Maternité Port Royal, 53, avenue de l'Observatoire, 75014 PARIS |
pierre-yves.ancel@inserm.fr | |
Unit | CRESS UR1153 |
Organization | Inserm Université de Paris |
Name of the director | TOUVIER |
Surname | Mathilde |
Address |
EREN, SMBH PARIS 13, 74 rue Marcel Cachin, F- 93017 Bobigny Cedex France |
m.touvier@eren.smbh.univ-paris13.fr | |
Unit | CRESS-EREN UMR U1153 Inserm |
Organization | Inserm - Sorbonne Paris Nord |
Collaborations | |
Participation in projects, networks and consortia |
Yes |
Details | Europe |
Funding | |
Funding status |
Public |
Details | ANR PIA |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Inserm |
Organisation status |
Public |
Presence of scientific or steering committees |
Yes |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Cohort study |
Database recruitment is carried out by an intermediary |
An administrative base or a register |
Base or register (detail) | CONSTANCES E3NE4N Nutrinet-Health Elfe and Epipage2 Cohorts |
Database recruitment is is made on the basis of: |
Another treatment or procedure |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Participants with an Internet connection |
Database objective | |
Main objective |
Based on the collection of capillary blood samples taken by the subjects, SAPRIS-SERO will help to:
Estimate the cumulative incidence of infection in the general population (objective 1a), Characterise the immune portion of the population and the durability of immunity (objective 1b). |
Inclusion criteria | Be a participant in one of the cohorts involved in the SAPRIS project, or a person sharing the same accommodation |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
General population |
Pathology | |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | excluding overseas regions and territories |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2020 |
Date of last collection (YYYY or MM/YYYY) | 2022 |
Size of the database | |
Size of the database (number of individuals) |
Greater than 20 000 individuals |
Details of the number of individuals | 88,000 participants from the SAPRIS study with at least one anti-SARS-CoV-2 serology time-point, |
Data | |
Database activity |
Current data collection |
Type of data collected |
Declarative data Biological data |
Declarative data (detail) |
Internet self-questionnaire |
Details of collected declarative data | cf. enquête SAPRIS |
Biological data (detail) | Capillary blood taken on blotting paper |
Presence of a biobank |
Yes |
Contents of biobank |
Others |
Details of biobank content | capillary blood dried on blotting paper |
Health parameters studied |
Health event/morbidity Health care consumption and services Quality of life/health perception |
Care consumption (detail) |
Hospitalization Medical/paramedical consultation |
Quality of life/perceived health (detail) | SF12 |
Procedures | |
Data collection method | online self-administered questionnaires |
Participant monitoring |
Yes |
Monitoring procedures |
Monitoring by contact with the participant (mail, e-mail, telephone etc.) |
Details on monitoring of participants | Follow-up serology - 2 sampling time-points (2021, 2022) |
Links to administrative sources |
Yes |
Linked administrative sources (detail) | Certain cohorts are paired with the SNDS database |
Promotion and access | |
Promotion | |
Access | |
Presence of document that lists variables and coding procedures |
Yes |
Terms of data access (charter for data provision, format of data, availability delay) | Available on request |
Access to aggregated data |
Free access |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05